The addition of sKl to SSc-MVECs resulted in significant progressive upregulation of Ki67 up to 48 hours (p < 0.05 for either 24-hour or 48-hour treatment versus the basal condition) (Fig. 4a). The gene discussed is MKI67; the disease is systemic sclerosis.